Key result
T wave amplitude corrected QT interval variability (cQTVi) significantly predicted all-cause mortality in patients with non-ischemic cardiomyopathy (p<0.01), whereas uncorrected QTV did not.
Why the study?
Does T wave amplitude correction of QT interval variability improve prediction of all-cause mortality in patients with non-ischemic dilated cardiomyopathy?
Observational (n=387)
Does T wave amplitude correction of QT interval variability improve prediction of all-cause mortality in patients with non-ischemic dilated cardiomyopathy?
Correcting QT interval variability for T wave amplitude significantly improves its prognostic value for predicting all-cause mortality in patients with non-ischemic cardiomyopathy.
OBJECTIVES: The inverse relationship between QT interval variability (QTV) and T wave amplitude potentially confounds QT variability assessment. We quantified the influence of the T wave amplitude on QTV in a comprehensive dataset and devised a correction formula. METHODS: Three ECG datasets of healthy subjects were analyzed to model the relationship between T wave amplitude and QTV. To derive a generally valid correction formula, linear regression analysis was used. The proposed correction formula was applied to patients enrolled in the Evaluation of Defibrillator in Non-Ischemic Cardiomyopathy Treatment Evaluation trial (DEFINITE) to assess the prognostic significance of QTV for all-cause mortality in patients with non-ischemic dilated cardiomyopathy. RESULTS: A strong inverse relationship between T wave amplitude and QTV was demonstrated, both in healthy subjects (R (2) = 0.68, p < 0.001) and DEFINITE patients (R (2) = 0.20, p < 0.001). Applying the T wave amplitude correction to QTV achieved 2.5-times better group discrimination between patients enrolled in the DEFINITE study and healthy subjects. Kaplan-Meier estimator analysis showed that T wave amplitude corrected QTVi is inversely related to survival (p < 0.01) and a significant predictor of all-cause mortality. CONCLUSION: We have proposed a simple correction formula for improved QTV assessment. Using this correction, predictive value of QTV for all-cause mortality in patients with non-ischemic cardiomyopathy has been demonstrated.
No takes yet. Share an insight, caveat, or question.
Schmidt et al. (2016) conducted an observational in Non-ischemic dilated cardiomyopathy and healthy subjects (n=387). T wave amplitude correction of QT interval variability (cQTVi) vs. Uncorrected QT interval variability (QTVi) was evaluated on All-cause mortality (p=<0.01). T wave amplitude corrected QT interval variability (cQTVi) significantly predicted all-cause mortality in patients with non-ischemic cardiomyopathy (p<0.01), whereas uncorrected QTV did not.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: